Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome

Status Recruiting

Clinical Trial Summary

In this study, the investigators conduct a remote, eight-week, two-arm, randomized controlled trial that assesses the benefits, primarily measured through the irritable bowel syndrome (IBS)-targeted HRQOL (health-related quality of life), of an immersive, disease-targeted virtual reality program compared to a non-immersive virtual reality program for patients with IBS.

Clinical Trial Description

In this study, the investigators will conduct a decentralized, remote, eight-week, two-arm, randomized controlled trial of SynerGI, a disease-targeted, brain-gut directed, immersive VR program for people with IBS, versus sham VR delivered in a VR headset. Eligible participants will be assigned to a study arm using a 1:1 random number generator and will be blinded to allocation. Data analysts will also be blinded to allocation; only pre-specified staff who are uninvolved with data analyses will be unblinded for purposes of study administration (e.g., sending allocation-specific study materials). After completion of the treatment, participants will be invited to participate in an optional 30-minute semi-structured interview to better understand their experiences of VR treatment. Qualitative interviews will be audio-recorded and transcribed. The primary aim of this study will be to assess the benefits of disease-targeted VR compared to sham VR on clinically relevant outcomes. The second aim will seek to determine patient-level predictors of treatment response to active VR therapy. The third aim will seek to understand patient experiences of VR to better inform the design of VR treatments for digestive diseases in the future. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06257472
Study type	Interventional
Source	The Cleveland Clinic
Contact	Anthony Lembo, MD
Phone	(216) 554-3531
Email	lemboa2@ccf.org
Status	Recruiting
Phase	N/A
Start date	June 2024
Completion date	February 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05118243` - Innovative Tools to Produce Legume-based Foods for Increased Consumer Acceptance	N/A
Completed	`NCT04422327` - The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome	Phase 1/Phase 2
Recruiting	`NCT05178017` - Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)	N/A
Completed	`NCT05197413` - Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms	N/A
Completed	`NCT04905524` - Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)	N/A
Recruiting	`NCT06297785` - Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)	N/A
Recruiting	`NCT05874830` - The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome	N/A
Active, not recruiting	`NCT04723056` - Zemedy Application for Irritable Bowel Syndrome	N/A
Completed	`NCT05565612` - Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome	N/A
Recruiting	`NCT03131414` - The IMAGINE-SPOR CIHR Chronic Disease Network
Completed	`NCT03333291` - Fecal Transplantation in Patients With IBS	N/A
Completed	`NCT03449628` - L. Casei DG® in Patients With Irritable Bowel Syndrome.	N/A
Recruiting	`NCT06215222` - Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
Completed	`NCT05016596` - Postprandial Lipids in IBS and Nutritional Treatment	N/A
Recruiting	`NCT04760353` - The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome	N/A
Completed	`NCT06426745` - Split-dose Versus Single-dose Bowel Preparation for Colonoscopy	N/A
Recruiting	`NCT04217733` - Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome	Phase 3
Completed	`NCT03178877` - The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors	N/A
Recruiting	`NCT05990764` - Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)	N/A
Completed	`NCT03948854` - Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients	N/A